Serial #85832109
LIVE

Serial Number

85832109

Owner

AGILENT TECHNOLOGIES, INC.

Attorney

Andrew Roppel

Filing Date

Jan 25, 2013

Add to watchlist:

No watchlists yet
View on USPTO

Serial #85832109 Trademark

Serial Number: 85832109 • Registration: 4406176

Serial #85832109 is a trademark filed by AGILENT TECHNOLOGIES, INC. on January 25, 2013. The trademark is classified under Class 1 (Chemicals). The application is currently registered and active.

Owner Contact Info

AGILENT TECHNOLOGIES, INC. (712 trademarks)

SANTA CLARA, CA 95051

Entity Type: 03

Trademark Details

Filing Date

January 25, 2013

Registration Date

September 24, 2013

Published for Opposition

July 9, 2013

Goods & Services

House mark for a full line of reagents for scientific or medical research use; house mark for a full line of chemicals for scientific purposes used in spectroscopy, mass spectrometry, chromatography and electrophoresis and for sample preparation for spectroscopy, mass spectrometry, chromatography and electrophoresis; chemicals used in industry and science, namely, for use in spectroscopy, mass spectrometry, chromatography, or electrophoresis or in sample preparation for spectroscopy, mass spectrometry, chromatography, or electrophoresis including standards all for scientific, clinical and scientific research use; reagents for scientific and research use; aqueous and organic solvents in the nature of chemical preparations for scientific and research use; cleaning detergents for industrial use, namely, for scientific and research use; chemicals for scientific purposes, namely, calibrants for performance verification of scientific instrumentation; ampholytes, namely, chemical products in the nature of preparations for scientific use for use in the separation and purification of any charge carrying molecule such as proteins and other molecules of biological origin as well as synthetic chemicals, these products being carrier ampholytes designed for use in isoelectric focusing, isotachophoresis and iso exchange chromatograph; chemicals, namely, buffer and standard solutions used in analytical chemistry; catalysts for chemical and biochemical processes; reagents, namely, matrices for scientific or medical research use; electrophoresis gels other than for medical or veterinary purposes; chromatography chemicals, namely, silica gel, polymers and solvents all for use in chromatography; purifying filtering and absorbing chemicals for use in industry, including for scientific and research use. solid phase extraction chemicals for use in the chromatography industry; chemical and biological standards, namely, chemical reagents for scientific and research use used in DNA, RNA and protein analysis; reagents for research purposes for scientific or medical research use; DNA labeling reagents for research purposes; DNA hybridization buffers, namely, reagents for research purposes for use in DNA hybridization; DNA cloning vectors, namely, reagents for scientific and research use; genomic cloning vectors, namely, reagents for scientific and research use; eukaryotic expression vectors, namely, reagents for scientific and research use; prokaryotic expression vectors, namely, reagents for scientific and research use; yeast shuttle vectors, namely, reagents for scientific and research use; competent cells, namely, reagents for scientific and research use; host cells, namely, reagents for scientific and research use; scientific and research laboratory reagents for molecular biological use, namely, packaging extracts used for inserting DNA into phages; polymerase chain reaction or PCR related products, namely, reagents for scientific and research use; nucleic acid markers, namely, reagents for scientific and research use; reagents used as protein standards for scientific, medical and research use; reagents used as synthetic peptide and protein digest standards for scientific and research use; reagents, namely, DNA primers and DNA vectors for scientific and research use; modifying enzymes not for medical use, namely, polymerase, nucleases, reverse transcriptases, ligases, kinases, phosphatases, glycosylases and transferases for scientific and research use; restriction enzymes for scientific and research use; media supplements, namely, reagents for scientific and research use. lymphokines, namely, reagents for scientific and research use; cytokines, namely, reagents for scientific and research use; kits for molecular biological research, namely, DNA cloning kits for scientific and research use said kits primarily comprising enzymes, reagents, and vectors; kits for molecular biological research, namely, genomic cloning kits for scientific and research use said kits primarily comprising enzymes, reagents, and vectors; kits for molecular biological research, namely, transfection kits for scientific and research use said kits primarily comprising enzymes, reagents, and vectors; kits for molecular biological research, namely, purification kits for scientific and research use said kits primarily comprising enzymes, reagents, and vectors; kits for molecular biological research, namely, polymerase chain reaction or PCR related cloning kits for scientific and research use said kits primarily comprising enzymes, reagents, and vectors; kits for molecular biological research, namely, ligase chain reaction or LCR kits for scientific and research use said kits primarily comprising enzymes, reagents, and vectors; kits for molecular biological research, namely, library construction kits for scientific and research use said kits primarily comprising enzymes, reagents, and vectors; kits for molecular biological research, namely, labeling kits for scientific and research use said kits primarily comprising enzymes, reagents, and vectors; kits for molecular biological research, namely, sequencing kits for scientific and research use said kits primarily comprising enzymes, reagents, and vectors; kits for molecular biological research, namely, mutagenesis kits for scientific and research use said kits primarily comprising enzymes, reagents, and vectors. kits for scientific and research use, namely, protein analysis kits said kits primarily comprising enzymes, reagents, and vectors; kits for molecular biological research, namely, transcription kits for scientific and research use said kits primarily comprising enzymes, reagents, and vectors; kits for molecular biological research, namely, translation kits for scientific and research use said kits primarily comprising enzymes, reagents, and vectors; and kits for molecular biological research, namely, in situ hybridization kits for scientific and research use said kits primarily comprising enzymes, reagents, and vectors

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Mar 2, 2024 NA89
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Mar 2, 2024 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Mar 2, 2024 89AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Mar 2, 2024 APRE
TEAS SECTION 8 & 9 RECEIVED
Sep 12, 2023 E89R
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Sep 24, 2022 REM2
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 23, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 23, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 23, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 23, 2022 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 23, 2022 COAR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 25, 2020 TCCA
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Aug 25, 2020 EWOR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 25, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 25, 2020 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jun 8, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 8, 2020 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 8, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 8, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jun 8, 2020 COAR
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Nov 3, 2019 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Nov 3, 2019 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Nov 3, 2019 APRE
TEAS SECTION 8 & 15 RECEIVED
Sep 24, 2019 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Sep 24, 2018 REM1
REGISTERED-PRINCIPAL REGISTER
Sep 24, 2013 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 9, 2013 NPUB
PUBLISHED FOR OPPOSITION
Jul 9, 2013 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 19, 2013 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jun 3, 2013 PREV
ASSIGNED TO LIE
Jun 3, 2013 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
May 16, 2013 CNSA
EXAMINER'S AMENDMENT ENTERED
May 16, 2013 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 16, 2013 GNEN
EXAMINERS AMENDMENT E-MAILED
May 16, 2013 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 16, 2013 CNEA
ASSIGNED TO EXAMINER
May 9, 2013 DOCK
NOTICE OF DESIGN SEARCH CODE MAILED
Jan 31, 2013 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 30, 2013 NWOS
NEW APPLICATION ENTERED
Jan 29, 2013 NWAP